Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Clin Nephrol ; 75(4): 328-35, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21426887

ABSTRACT

BACKGROUND: Hereditary hemochromatosis is an autosomal recessive condition causing excessive intestinal iron absorption related to C282Y hemochromatosis mutation gene. Dialysis patients receive intravenous iron supplements as treatment for anemia. The gene mutation frequency and its influence on iron deposits and intravenous iron response are unknown in these patients. STUDY DESIGN: Prospective observational. SETTING AND PARTICIPANTS: 290 dialysis patients in Gran Canaria, Spain. OUTCOMES AND MEASUREMENTS: The C282Y hemochromatosis mutation gene was studied. Other active players in iron metabolism have not been included in this study. Red cell parameters, serum iron, transferrin and ferritin concentrations were measured every 2 months for 2 years. RESULTS: No differences in allelic and genotypic frequencies between dialysis patients and the general population were detected. Baseline clinical or analytical parameters were similar in C282Y +/- and C282Y -/- patients. Among those who did not need intravenous iron treatment, C282Y+/- patients maintained constant serum ferritin (302.1 ± 216.7 vs. 319.5 ± 300.5 µg/l after 4 months), whereas C282Y-/- patients showed decreased levels during the same period (306.7 ± 212.2 vs. 221.6 ± 167.8 µg/l, p < 0.001). After 4 months of parenteral iron, serum ferritin increased more intensely in C282Y +/- patients than in C282Y -/- patients (934.2 ± 195.8 vs. 658.7 ± 259.9 µg/l, p < 0.001). A multivariance analysis identified the C282Y allele as the most important factor that explains this difference. CONCLUSIONS: Heterozygosity for the C282Y allele of the hemochromatosis mutation gene could be associated with differences in iron parameters in dialysis patients.


Subject(s)
Hemochromatosis/genetics , Histocompatibility Antigens Class I/genetics , Iron/blood , Membrane Proteins/genetics , Mutation, Missense , Renal Dialysis , Alleles , Analysis of Variance , Antigens, Surface/genetics , Chi-Square Distribution , Female , Genotype , Hemochromatosis/blood , Hemochromatosis/drug therapy , Hemochromatosis Protein , Humans , Iron/therapeutic use , Male , Middle Aged , Polymerase Chain Reaction , Statistics, Nonparametric
2.
Transplant Proc ; 42(8): 3063-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20970611

ABSTRACT

BACKGROUND/AIMS: An early, simple, and reliable marker for acute pancreatic allograft rejection is not available. Inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) is an interleukin-6-dependent acute-phase positive protein that can act as an anti-inflammatory protein. We studied the response of the ITIH4 in pigs undergoing pancreas allotransplantation (PT) and evaluated this protein as a biomarker for acute graft rejection. METHODS: PT with enteric drainage of the exocrine secretion and systemic venous drainage was performed on 12 Landrace pigs. No immunosuppression was administered. Serum concentrations of glucose, amylase, lipase, insulin, C-peptide, and ITIH4 were determined daily. RESULTS: The response of ITIH4 to PT was early, intense, and prolonged, with 2 peaks in serum concentration. The first peak, which started on day 1 and reached maximum (around 6 mg/dL) on day 3, was attributed to the systemic acute phase response to surgical stress. The second peak, which exceeded the first peak and reached maximum (>8 mg/dL) on day 6, began when the recipients were still normoglycemic, and preceded onset of the diabetic state caused by acute graft rejection by an average of 4 days. CONCLUSION: Serum ITIH4 could help to predict subclinical acute graft rejection after PT in pigs.


Subject(s)
Alpha-Globulins/metabolism , Biomarkers/blood , Graft Rejection/blood , Pancreas Transplantation , Animals , Swine , Transplantation, Homologous
3.
J Vet Diagn Invest ; 13(2): 106-10, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11289204

ABSTRACT

A comparative study of 3 analytical methods (immunoradiometric assay, enzyme immunometric assay, and chemiluminescent immunometric assay) for canine serum thyrotropin (TSH) was performed. Ninety-six dogs were included in the study. The within- and between-run precision was evaluated for each method, and correlations for the results obtained with each method were examined. The best within- and between-run precision was obtained with the chemiluminescent immunometric assay. Satisfactory correlations for the 3 analytical procedures were obtained but varied in relation to serum TSH concentration.


Subject(s)
Dog Diseases/diagnosis , Dogs/immunology , Hypothyroidism/veterinary , Immunoassay/veterinary , Thyrotropin/blood , Animals , Dogs/blood , Female , Hypothyroidism/diagnosis , Immunoassay/standards , Immunoenzyme Techniques/veterinary , Immunoradiometric Assay/veterinary , Luminescent Measurements , Male , Predictive Value of Tests , Sensitivity and Specificity , Thyrotropin/immunology
4.
J Trace Elem Med Biol ; 14(2): 65-70, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10941714

ABSTRACT

The levels and distribution of serum Cu and Zn were studied in patients diagnosed with acute myocardial infarction from the day of admission to the Cardiovascular Intensive Care Unit until the 10th day following the attack. The results obtained show that Cu increases significantly (p < 0.01) after the 5th day after the acute myocardial infarction, while Zn decreases significantly (p < 0.01) with respect to the control group from the first day on, with the lowest values being found on the 3rd day after the attack. Further, total serum Cu showed an excellent correlation with the albumin-bound and globulin-bound Cu (ceruloplasmin), as well as with the concentrations of both serum protein fractions. In contrast, total serum Zn only presents this correlation with Zn bound to albumin, but not with Zn bound to globulin nor with the albumin concentration. These findings suggest the existence of some type of relationship between the two fractions of the element bound to protein. This relationship is probably different for both metals.


Subject(s)
Copper/blood , Myocardial Infarction/blood , Zinc/blood , Adult , Aged , Ammonium Sulfate/pharmacology , Case-Control Studies , Ceruloplasmin/metabolism , Female , Humans , Kinetics , Longitudinal Studies , Male , Middle Aged , Myocardial Infarction/metabolism , Reproducibility of Results , Spectrophotometry, Atomic , Time Factors
5.
Cir. Esp. (Ed. impr.) ; 68(2): 111-115, ago. 2000. ilus, tab
Article in Es | IBECS | ID: ibc-5561

ABSTRACT

Introducción. El hiperparatiroidismo primario por adenoma, identificado y localizado por ecografía y gammagrafía, puede ser tratado mediante un acceso limitado, bajo anestesia local y sedación, con la condición de controlar el efecto de la exéresis mediante la dosificación intraoperatoria de la parathormona intacta (PTH-i), y respetar las limitaciones y/o contraindicaciones de esta técnica. Pacientes y método. Se analizan los resultados obtenidos en el tratamiento de 14 pacientes afectados por un hiperparatiroidismo ocasionado por un adenoma de paratiroides (localizado por ecografía y gammagrafía) mediante cirugía selectiva bajo anestesia local y sedación con monitorización intraoperatoria de la PTH-i. Resultados. La anestesia local y la posición operatoria fueron bien toleradas y no hubo complicaciones locales ni re currenciales. La exéresis del adenoma en el orden técnico, no planteó ninguna dificultad. El éxito de la operación se confirmó durante el acto operatorio al comprobar la normalización de los valores de PTH-i a los 30 y 60 minutos tras la exéresis lesional. Conclusiones. La cuestión que subyace es si este método podrá sustituir al acceso quirúrgico tradicional. No obstante, la adenomectomía selectiva paratiroidea, con anestesia local y sedación constituye, en caso de monitorización de la PTH-i, el preludio de una cervicotomía estándar bajo anestesia general (AU)


Subject(s)
Adult , Aged , Female , Male , Middle Aged , Humans , Hyperparathyroidism/surgery , Hyperparathyroidism/pathology , Adenoma/surgery , Adenoma/pathology , Anesthesia, Local , Anesthesia, Local/methods , Parathyroid Neoplasms/surgery , Parathyroid Neoplasms/diagnosis , Parathyroid Neoplasms/etiology , Ultrasonography , Hypocalcemia/surgery , Hypocalcemia/complications , Hypocalcemia/diagnosis , Hypocalcemia/etiology , Parathyroid Glands/surgery , Parathyroid Glands/pathology , Anesthesia
6.
Rev Esp Fisiol ; 44(2): 179-84, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3194574

ABSTRACT

The purpose of this work was to estimate the 24 h urinary excretion of free and conjugated triiodotironine (T3) using a direct radioimmunoassay and enzyme hydrolysis. Mean urinary values of free and total T3 (mean +/- 1 SD) in euthyroid controls were 2074 +/- 673 and 2819 +/- 809 pmol/24 h respectively. In patients with hyperthyroidism, values of free hormone were about 4.2 times higher than the mean value of the euthyroid controls, and about one-third in patients with hypothyroidism. These results show this measurement to be useful as an indicator of thyroid function. Mean renal clearance of free T3 was 211.6 +/- 62.8 ml/min (mean +/- 1 SD) in euthyroid controls, 260.8 +/- 87.5 ml/ml in hyperthyroid patients and 229 +/- 98.7 ml/min in hypothyroid patients. The data show that T3 renal clearance is, in all cases, greater than glomerular filtration rate, suggesting tubular secretion of T3.


Subject(s)
Hyperthyroidism/urine , Hypothyroidism/urine , Triiodothyronine/urine , Adult , Aged , Circadian Rhythm , Female , Humans , Hyperthyroidism/blood , Hypothyroidism/blood , Kidney/metabolism , Male , Middle Aged , Triiodothyronine/blood
7.
Acta Endocrinol (Copenh) ; 114(4): 503-8, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3577582

ABSTRACT

The aim of this work was to estimate the daily urinary excretion of free and conjugated thyroxine using a direct radioimmunoassay and enzyme hydrolysis. The renal clearance of free T4 was also determined. The mean urinary values of free and total T4 (mean +/- 1 SD) in 112 euthyroid controls were 1353 +/- 496 and 1855 +/- 651 pmol/24 h, respectively. Urinary excretion of free hormone in 13 hyperthyroid patients was 5552 +/- 4320 pmol/24 h and total T4 was 8122 +/- 7219 pmol/24 h. Urinary free T4 excretion was 223 +/- 223 pmol/24 h in hypothyroid patients and total T4 was 542 +/- 490 pmol/24 h. These results indicate that daily urinary T4 excretion is a good indicator of thyroid function. The mean renal clearance of free T4 was 52 +/- 19 ml/min (mean +/- 1 SD) in euthyroid patients, 53.7 +/- 12.3 ml/min in hyperthyroid patients, and 67.6 +/- 13.1 ml/min in hypothyroid patients. We estimated the endogenous creatinine renal clearance as a control of the renal filtration rate. The data suggest that there is T4 filtration of unbound T4 and partial tubular reabsorption. Further experimental studies will be necessary to clarify the renal handling of thyroxine as well as the fate of reabsorbed T4.


Subject(s)
Thyroxine/urine , Adult , Creatinine/metabolism , Female , Glucuronidase/metabolism , Humans , Hydrolysis , Hyperthyroidism/urine , Hypothyroidism/urine , Kidney/metabolism , Male , Radioimmunoassay
SELECTION OF CITATIONS
SEARCH DETAIL
...